Day 2 - PST/PDT (Pacific Daylight, GMT-7)
Day 2 - PST/PDT (Pacific Daylight, GMT-7)
Hear from an inspiring and enlightening patient advocacy organization about their mission and how industry stakeholders can become better partners in overcoming the challenges of patient access.
- Ronnie Sharpe - Founder & Chief Operations Officer, Savvy Cooperative
- Discuss program design strategies that manufacturers should consider to allow scalability and adaptability of hub programs
- Learn how implementing these strategies improves the patient experience, and how to prioritize the patient through expanding your hub
- Geoffrey Koren - Independent Consultant, Koren Consulting
- Nancy Bell - Vice President, Head of US Patient Value & Access, Takeda Oncology
With patient support as a core part of the biopharma commercial strategy, specialty therapies are seeking expertise in both Hub Services and patient engagement to enhance the overall patient experience and improve adherence.
Innovative companies are seeking patient engagement providers alongside a HUB to provide specialized expertise, access to technologies, collaboration benefits, and advanced data analytics. These advantages contribute to more effective, patient-centric support for specialty therapies, ultimately improving patient outcomes.
In this presentation, we’ll discuss:
A shift towards adding a patient engagement provider to the support ecosystem and key advantages of leveraging specialized expertise
Best practices and learnings on what’s required for both entities to be coordinated, and in-market ways individual HUB and patient engagement providers have partnered
Examples of how patient engagement providers are increasing HUB impact
- Andrea Heslin Smiley - CEO and President, VMS BioMarketing
- Discuss the importance of prioritizing marketing and hub/patient support strategy alignment to optimize cross-functional collaboration
- Explore how to effectively communicate the value of patient support programs to marketing and other departments to ensure a full understanding of the purpose of PSPs and that brand messaging is spreading the right message to patients
- Discuss best practices, effective strategies and what firewalls need to remain in place to optimize operations
- Bridget Olson, PharmD, MS - Independent Consultant, Co-Architect FormularyDecisions
- Jackie Barnard - Associate Director, Field Reimbursement & Patient Services, Paratek Pharmaceuticals
- Jeff Park - Senior Director, Patient Support Services, Cytokinetics
Discuss the key considerations manufacturers must prioritize during the vendor selection process to ensure program success
Learn how to strategize in the vendor selection process to determine what services you need, program development and how your hub can work cohesively to deliver the best patient experience
- Daniel Johnson - Senior Director of Product Marketing, Phil Inc.
- Lakia Lewis-Latin - Director, Program Management Strategy, Abbvie
Attendees drive the dialogue for these tailored talks. Select your topic, join the table and share insights/best practices with industry counterparts. Topics for selection include:
- Hub Model Strategies
- Stakeholder Collaboration
- Regulatory/Compliance